Identifying Personalised treatment plan for GBM using Multidimensional Patient Similarity Analytics
DOI:
https://doi.org/10.47392/irjash.2023.S011Keywords:
Glioblastma Multiform, Machine Learning models, Clustering, Patient similarity, Cancer survivalAbstract
International Agency for Research on Cancer (IACR) reported an increase in
the worldwide cancer rate which is now known to be a major impediment to
increasing life expectancy. Glioblastoma multiform, further named as astrocytoma, is a fast-growing truculent type of brain tumour that develops in the
cerebral hemispheres, mainly in the frontal and temporal lobes of the brain.
According to the National Brain Tumor Society, GBM accounts for 49.1 percent of all primary malignant brain tumors. Despite advances in the available
treatment options, there is not much improvement in overall patient survival
rate and still ranges from 14.6 to 20.5months. Also, some individuals show
adverse drug reactions due to their genetic composition, and the condition is
called idiosyncrasy. The proposed work aims to find an effective treatment
strategy for GBM patients on the basis of their clinical and genomic factors.
The work is presented based on Genomic Data Commons (GDC), cBioportal
and Cancer Browser dataset. Here we develop different patient cohorts based
on the predictive features using K-means++ algorithm. A test patient acquires
the treatment pattern of its most similar neighbour using patient similarity analytics. This is a generalized approach that can be applied to any disease class
where personal traits have impact on overall survival.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.